Patrick Flamen

1 ta ish

Active Medicine (United Kingdom)

1. Clinical added-value of 18FDG PET in neuroendocrine-merkel cell carcinoma

   Tarik Belhocine, Gérald Pierard, J Frühling +6

   MaqolaOAOchiq kirish20062 iqtibos

   ABIABI:AkademIndex/2026.other.1036986